A prospective, open-label, multi-site, FIH with up to fifteen (n=15) patients to assess the safety and preliminary effectiveness of the AVS Pulse Intravascular Lithotripsy™ System (Pulse IVL™ System) when used for the treatment of coronary artery disease.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
15
The Pulse Intravascular Lithotripsy (Pulse IVL) System is used for the treatment of severely calcified stenotic de novo coronary arteries prior to stenting in patients with coronary artery disease.
Monash Health, Victorian Heart Hospital
Melbourne, Victoria, Australia
RECRUITINGAuckland City Hospital
Auckland, New Zealand
RECRUITINGAchieve residual stenosis (<50%) in conjunction with stenting in the absence of major device related adverse events
Time frame: Completion of study procedure
Target lesion failure (TLF)
Time frame: Within 30 days of study procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.